(Q41413269)

30 September 2017

1 reference

title

Role of complement and Fc receptors in the pathogenesis of HIV-1 infection (English)

1 reference

30 September 2017

Montefiori DC

1

1 reference

30 September 2017

publication date

1 January 1997

1 reference

Seminars in Immunopathology

30 September 2017

published in

1 reference

30 September 2017

volume

18

1 reference

30 September 2017

issue

3

1 reference

30 September 2017

page(s)

371-390

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00813504

30 September 2017

exact match

0 references

cites work

Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor

1 reference

12 December 2020

Circulating immune complexes in patients with acquired immune deficiency syndrome contain the AIDS-associated retrovirus

1 reference

12 December 2020

AIDS-associated non-Hodgkin lymphoma

1 reference

12 December 2020

1 reference

12 December 2020

Candidate AIDS vaccines

1 reference

12 December 2020

Circulating levels of mannose binding protein in human immunodeficiency virus infection

1 reference

12 December 2020

Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55).

1 reference

12 December 2020

Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene.

1 reference

12 December 2020

Heightened complement sensitivity of acquired immunodeficiency syndrome lymphocytes related to diminished expression of decay-accelerating factor

1 reference

12 December 2020

Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection

1 reference

12 December 2020

Fc receptors for IgG (Fc gamma Rs) on human monocytes and macrophages are not infectivity receptors for human immunodeficiency virus type 1 (HIV-1): studies using bispecific antibodies to target HIV-1 to various myeloid cell surface molecules, inclu

1 reference

12 December 2020

Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials

1 reference

12 December 2020

Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement

1 reference

12 December 2020

The AIDS-associated retrovirus is not sensitive to lysis or inactivation by human serum.

1 reference

12 December 2020

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

1 reference

12 December 2020

Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity

1 reference

12 December 2020

Lymphocytotropic strains of HIV type 1 when complexed with enhancing antibodies can infect macrophages via Fc gamma RIII, independently of CD4.

1 reference

12 December 2020

The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells

1 reference

12 December 2020

IgG subclass responses to a transmembrane protein (gp41) peptide in HIV infection

1 reference

12 December 2020

Regulation by membrane sialic acid of β1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway

1 reference

12 December 2020

Human T lymphocytes expressing the C3b/C4b complement receptor type one (CR1, CD35) belong to Fc gamma receptor-positive CD4-positive T cells

1 reference

12 December 2020

Complement-mediated, antibody-dependent enhancement of HIV-1 infection in vitro is characterized by increased protein and RNA syntheses and infectious virus release

1 reference

12 December 2020

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

12 December 2020

Germinal centres in T-cell-dependent antibody responses

1 reference

12 December 2020

Follicular dendritic cells (FDC) are not productively infected with HIV-1 in vivo

1 reference

12 December 2020

Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21).

1 reference

12 December 2020

Human HIV vaccine trials: does antibody-dependent enhancement pose a genuine risk?

1 reference

12 December 2020

The use of yellow fever virus modified by in vitro cultivation for human immunization

1 reference

12 December 2020

Binding of human immunodeficiency virus type 1 to the C3b/C4b receptor CR1 (CD35) and red blood cells in the presence of envelope-specific antibodies and complement. National Institutes of Health AIDS Vaccine Clinical Trials Networks

1 reference

12 December 2020

Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals

1 reference

12 December 2020

Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III.

1 reference

12 December 2020

The complement system: its importance in the host response to viral infection

1 reference

12 December 2020

Activation of the alternative complement pathway by mumps infected cells: relationship to viral neuraminidase activity.

1 reference

12 December 2020

Do antibodies enhance the infection of cells by HIV?

1 reference

12 December 2020

Decreased expression of the membrane inhibitor of complement-mediated cytolysis CD59 on T-lymphocytes of HIV-infected patients

1 reference

12 December 2020

Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens.

1 reference

12 December 2020

Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody

1 reference

12 December 2020

HIV-1 and HIV-2 isolates differ in their ability to activate the complement system on the surface of infected cells

1 reference

12 December 2020

Polymeric C3dg primes human B lymphocytes for proliferation induced by anti-IgM.

1 reference

12 December 2020

Lack of enhancing effect of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of human blood monocytes and peritoneal macrophages

1 reference

12 December 2020

In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody.

1 reference

12 December 2020

Patterns of antibodies to human immunodeficiency virus proteins in different subclasses of IgG.

1 reference

12 December 2020

Absence of a clinical correlation for complement-mediated, infection-enhancing antibodies in plasma or sera from HIV-1-infected individuals. Multicenter AIDS Cohort Study Group

1 reference

12 December 2020

Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).

1 reference

12 December 2020

Isotypic restriction of the antibody response to human immunodeficiency virus

1 reference

12 December 2020

Alternative complement pathway activation by HIV infected cells: C3 fixation does not lead to complement lysis but enhances NK sensitivity

1 reference

12 December 2020

The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network

1 reference

12 December 2020

V3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1

1 reference

12 December 2020

Human immunodeficiency virus infection of monocytes: relationship to Fc-gamma receptors and antibody-dependent viral enhancement

1 reference

12 December 2020

Assembly of asparagine-linked oligosaccharides

1 reference

12 December 2020

Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59

1 reference

12 December 2020

Antibody-dependent enhancement of viral infectivity.

1 reference

12 December 2020

Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

1 reference

12 December 2020

The role of the carbohydrate chains in complement (C3) fixation by solid-phase-bound human IgA.

1 reference

12 December 2020

The maintenance and regulation of serum antibody levels: evidence indicating a role for antigen retained in lymphoid follicles

1 reference

12 December 2020

Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.

1 reference

12 December 2020

C3d of complement as a molecular adjuvant: bridging innate and acquired immunity

1 reference

12 December 2020

Complement and antibody mediate enhancement of HIV infection by increasing virus binding and provirus formation

1 reference

12 December 2020

Inhibition of serum-enhanced HIV-1 infection of U937 monocytoid cells by recombinant soluble CD4 and anti-CD4 monoclonal antibody

1 reference

12 December 2020

Infection of monocytes by human immunodeficiency virus type 1 blocked by inhibitors of CD4-gp120 binding, even in the presence of enhancing antibodies

1 reference

12 December 2020

HIV infection of monocytic cells: rôle of antibody-mediated virus binding to Fc-gamma receptors

1 reference

12 December 2020

Molecular organization and function of the complement system

1 reference

12 December 2020

Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41

1 reference

12 December 2020

Two receptors are required for antibody-dependent enhancement of human immunodeficiency virus type 1 infection: CD4 and Fc gamma R.

1 reference

12 December 2020

Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade

1 reference

12 December 2020

Direct Interaction of Complement Factor H with the C1 Domain of HIV Type 1 Glycoprotein 120

1 reference

12 December 2020

Cytotoxicity mediated by human Fc receptors for IgG.

1 reference

12 December 2020

Serum antibodies to HIV-1 in recombinant vaccinia virus recipients boosted with purified recombinant gp160. NIAID AIDS Vaccine Clinical Trials Network

1 reference

12 December 2020

Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro

1 reference

12 December 2020

Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation

1 reference

12 December 2020

Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion

1 reference

12 December 2020

Suppression of the Immune Response by a Soluble Complement Receptor of B Lymphocytes

1 reference

12 December 2020

Complement-fixing properties of human IgA antibodies. Alternative pathway complement activation by plastic-bound, but not specific antigen-bound, IgA

1 reference

12 December 2020

Growth control of activated, synchronized murine B cells by the C3d fragment of human complement

1 reference

12 December 2020

Biological activities of immunoglobulins of different classes and subclasses.

1 reference

12 December 2020

Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes

1 reference

12 December 2020

pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane

1 reference

12 December 2020

High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection

1 reference

12 December 2020

IgM natural antibody against an asialo-oligosaccharide, gangliotetraose (Gg4), sensitizes HIV-I infected cells for cytolysis by homologous complement

1 reference

12 December 2020

Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri.

1 reference

12 December 2020

Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent.

1 reference

12 December 2020

IgG, IgM, and IgA response to HIV in infants born to HIV-1 infected mothers. Swiss Neonatal HIV Study Group.

1 reference

12 December 2020

Glomerular lesions in the acquired immunodeficiency syndrome

1 reference

12 December 2020

Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors

1 reference

12 December 2020

Human immunodeficiency virus infection of CD4-bearing cells occurs by a pH-independent mechanism

1 reference

12 December 2020

T alpha cell subsets in human peripheral blood

1 reference

12 December 2020

Infectious immune complexes in HIV-1-infected patients

1 reference

12 December 2020

Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptors

1 reference

12 December 2020

Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection

1 reference

12 December 2020

CD23/CD21 interaction is required for presentation of soluble protein antigen by lymphoblastoid B cell lines to specific CD4+ T cell clones.

1 reference

12 December 2020

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Direct binding of complement component C1q to human immunodeficiency virus (HIV) and human T lymphotrophic virus-I (HTLV-I) coinfected cells

1 reference

12 December 2020

The epidemiology of AIDS-associated non-Hodgkin's lymphoma in the World Health Organization European Region

1 reference

12 December 2020

High prevalence of serum IgA HIV-1 infection-enhancing antibodies in HIV-infected persons. Masking by IgG.

1 reference

12 December 2020

Phenotypic analysis of complement receptor 2+ T lymphocytes: reduced expression on CD4+ cells in HIV-infected persons

1 reference

12 December 2020

The control of homologous lysis

1 reference

12 December 2020

Evidence for activation of complement in patients with AIDS related complex (ARC) and/or lymphoadenopathy syndrome (LAS)

1 reference

12 December 2020

Complement receptor 2 mediates enhancement of human immunodeficiency virus 1 infection in Epstein-Barr virus-carrying B cells

1 reference

12 December 2020

Association of T cell and macrophage dysfunction with surface gp 120-immunoglobulin-complement complexes in HIV-infected patients

1 reference

12 December 2020

Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials Network.

1 reference

12 December 2020

Hematologic correlates and the role of erythrocyte CR1 (C3b receptor) in the development of AIDS.

1 reference

12 December 2020

Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus

1 reference

12 December 2020

Antibody-independent, complement-mediated enhancement of HIV-1 infection by mannosidase I and II inhibitors

1 reference

12 December 2020

The role of C3 in the immune response

1 reference

12 December 2020

Role of the mononuclear phagocyte system in the immunopathogenesis of human immunodeficiency virus infection and the acquired immunodeficiency syndrome

1 reference

12 December 2020

1 reference

12 December 2020

Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines

1 reference

12 December 2020

The spleen as a filter

1 reference

12 December 2020

New insights into the role of host cell proteins in antiviral vaccine protection

1 reference

12 December 2020

Direct detection of infectious human immunodeficiency virus type 1 (HIV-1) immune complexes in the sera of HIV-1-infected persons

1 reference

12 December 2020

Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1

1 reference

12 December 2020

Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome.

1 reference

12 December 2020

Are B lymphocytes the principal antigen-presenting cells in vivo?

1 reference

12 December 2020

Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome

1 reference

12 December 2020

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

12 December 2020

Complement activation by recombinant HIV-1 glycoprotein gp120

1 reference

12 December 2020

CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes

1 reference

12 December 2020

Immunoglobulin class and subclass antibodies to HIV proteins in maternal serum: association with perinatal transmission

1 reference

12 December 2020

Inhibition of the complement cascade by the major secretory protein of vaccinia virus

1 reference

12 December 2020

B-cell memory is short-lived in the absence of antigen.

1 reference

12 December 2020

Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity

1 reference

12 December 2020

Bispecific antibody targeting of human immunodeficiency virus type 1 (HIV-1) glycoprotein 41 to human macrophages through the Fc IgG receptor I mediates neutralizing effects in HIV-1 infection

1 reference

12 December 2020

All forms of human IgA antibodies bound to antigen interfere with complement (C3) fixation induced by IgG or by antigen alone

1 reference

12 December 2020

CD4-independent binding of HIV-1 to the B lymphocyte receptor CR2 (CD21) in the presence of complement and antibody

1 reference

12 December 2020

Membrane complement receptors specific for bound fragments of C3.

1 reference

12 December 2020

Studies of complement-activating antibodies in the SIV/macaque model of acute primary infection and vaccine protection

1 reference

12 December 2020

CR1 (CD35) and CR3 (CD11b/CD18) mediate infection of human monocytes and monocytic cell lines with complement-opsonized HIV independently of CD4.

1 reference

12 December 2020

CR1(CD35) and CR2(CD21) complement C3 receptors are expressed on normal human thymocytes and mediate infection of thymocytes with opsonized human immunodeficiency virus

1 reference

12 December 2020

Antibody-dependent enhancement of HIV-1 infection in human term syncytiotrophoblast cells cultured in vitro

1 reference

12 December 2020

Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120.

1 reference

12 December 2020

Complement receptors: another port of entry for HIV

1 reference

12 December 2020

Carbohydrate structures of the human-immunodeficiency-virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese-hamster ovary cells

1 reference

12 December 2020

Protection against Japanese encephalitis by inactivated vaccines

1 reference

12 December 2020

Monoclonal antibodies to the 140,000 mol wt glycoprotein of B lymphocyte membranes (CR2 receptor) initiates proliferation of B cells in vitro

1 reference

12 December 2020

Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo

1 reference

12 December 2020

Biology of complement: the overture

1 reference

12 December 2020

Complement-mediated enhancement of HIV-1 infection of the monoblastoid cell line U937.

1 reference

12 December 2020

New concepts in the immunopathogenesis of HIV infection

1 reference

12 December 2020

The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms

1 reference

12 December 2020

Intraclonal generation of antibody mutants in germinal centres

1 reference

12 December 2020

Monovalent ligands of complement receptor 2 inhibit whereas polyvalent ligands enhance anti-Ig-induced human B cell intracytoplasmic free calcium concentration

1 reference

12 December 2020

Decreased expression of the C3b/C4b complement receptor (CR1) in AIDS and AIDS-related syndromes correlates with clinical subpopulations of patients with HIV infection

1 reference

12 December 2020

Mannan-binding protein, a complement activating animal lectin

1 reference

12 December 2020

In vivo decrease in the expression of complement receptor 2 on B-cells in HIV infection

1 reference

12 December 2020

An anti-gp41 human monoclonal antibody that enhances HIV-1 infection in the absence of complement

1 reference

12 December 2020

Complement receptor type 2 mediates infection of the human CD4-negative Raji B-cell line with opsonized HIV

1 reference

12 December 2020

Effect of heat and fresh human serum on the infectivity of human T-cell lymphotropic virus type III evaluated with new bioassay systems

1 reference

12 December 2020

Further characterization of the interaction between the C1q subcomponent of human C1 and the transmembrane envelope glycoprotein gp41 of HIV-1.

1 reference

12 December 2020

The follicular dendritic cell: its role in antigen presentation in the generation of immunological memory

1 reference

12 December 2020

Immune enhancement of viral infection

1 reference

12 December 2020

HIV and HIV-infected cells differentially activate the human complement system independent of antibody

1 reference

12 December 2020

Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines

1 reference

12 December 2020

Antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus type 1 infection in a human, Epstein-Barr virus-transformed B-lymphocytic cell line

1 reference

12 December 2020

Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection

1 reference

12 December 2020

Follicular dendritic cells and human immunodeficiency virus infectivity

1 reference

12 December 2020

CR2 ligands modulate human B cell activation

1 reference

12 December 2020

Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1

1 reference

12 December 2020

Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV

1 reference

12 December 2020

Complement and virus-specific antibody-dependent infection of normal B lymphocytes by human immunodeficiency virus type 1.

1 reference

12 December 2020

Activation of the alternative complement pathway by enveloped viruses containing limited amounts of sialic acid

1 reference

12 December 2020

Antibodies and complement enhance binding and uptake of HIV-1 by human monocytes

1 reference

12 December 2020

A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals

1 reference

12 December 2020

Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein

1 reference

12 December 2020

Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro

1 reference

12 December 2020

Antibody-dependent enhancement of simian immunodeficiency virus (SIV) infection in vitro by plasma from SIV-infected rhesus macaques

1 reference

12 December 2020

Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins

1 reference

12 December 2020

Relation of circulating levels of human immunodeficiency virus (HIV) antigen, antibody to p24, and HIV-containing immune complexes in HIV-infected patients

1 reference

12 December 2020

Complement Activation by gp160 Glycoprotein of HIV-1

1 reference

12 December 2020

Binding of complement component C3b to glycoprotein C is modulated by sialic acid on herpes simplex virus type 1-infected cells.

1 reference

12 December 2020

Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus

1 reference

12 December 2020

Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry

1 reference

12 December 2020

Ultracentifuge studies of the binding of IgG of different subclasses to the Clq subunit of the first component of complement

1 reference

12 December 2020

Antibody-dependent enhancement of human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Detection of anti-human cell antibodies in sera from macaques immunized with whole inactivated virus

1 reference

12 December 2020

Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00813504

1 reference

30 September 2017

1 reference